Quantbot Technologies LP Invests $5.30 Million in Ralliant Corporation $RAL

Quantbot Technologies LP acquired a new stake in Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 71,994 shares of the company’s stock, valued at approximately $5,301,000. Quantbot Technologies LP owned approximately 0.07% of Ralliant at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Dunhill Financial LLC purchased a new position in Ralliant during the 2nd quarter worth $25,000. Global Retirement Partners LLC acquired a new position in Ralliant during the 2nd quarter worth approximately $35,000. Danske Bank A S purchased a new position in Ralliant in the fourth quarter worth $25,000. Persistent Asset Partners Ltd purchased a new position in shares of Ralliant in the 2nd quarter valued at about $37,000. Finally, Allworth Financial LP boosted its stake in shares of Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares in the last quarter.

Wall Street Analyst Weigh In

A number of brokerages recently commented on RAL. Weiss Ratings reissued a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. BMO Capital Markets began coverage on shares of Ralliant in a report on Monday, July 20th. They set a “market perform” rating and a $78.00 price target for the company. TD Cowen raised their price target on Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Vertical Research lowered shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target for the company. in a research report on Wednesday, May 27th. Finally, Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $75.70.

Ralliant Stock Performance

Shares of NYSE:RAL opened at $63.72 on Friday. The business’s 50-day simple moving average is $68.94 and its 200 day simple moving average is $55.92. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The company has a market cap of $7.05 billion, a P/E ratio of -5.87, a PEG ratio of 2.36 and a beta of 1.60.

Ralliant (NYSE:RAL) last announced its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. The business had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, sell-side analysts forecast that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a yield of 0.3%. Ralliant’s payout ratio is currently -1.84%.

Insider Activity at Ralliant

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the company’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the transaction, the chief executive officer directly owned 251,967 shares of the company’s stock, valued at $18,088,710.93. This represents a 4.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the transaction, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. This trade represents a 16.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by insiders.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.